Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Published in Oncology

Journal Scan / Research · January 30, 2015

Bendamustine and Rituximab Combined for CLL-Associated Autoimmune Hemolytic Anemia

American Journal of Hematology

 

 Save  Recommend
 Share

Additional Info

American Journal of Hematology
Bendamustine and Rituximab Combination in the Management of Chronic Lymphocytic Leukemia-Associated Autoimmune Hemolytic Anemia: A Multicentric Retrospective Study of the French CLL Intergroup (GCFLLC/MW and GOELAMS)
Am. J. Hematol 2015 Jan 16;[EPub Ahead of Print], A Quinquenel, C Willekens, J Dupuis, B Royer, L Ysebaert, S DeGuibert, AS Michallet, P Feugier, R Guieze, V Levy, A Delmer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated